Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures - Concepedia

Concepedia

Publication | Closed Access

Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures

445

Citations

10

References

2000

Year

Simon Shorvon, Armand Löwenthal, Diéter Janz, E Bieleń, P Loiseau

Abstract

The antiepileptic efficacy and tolerability of LEV (1,000 mg/d and 2,000 mg/d, administered in two divided doses) as add-on therapy was established in patients with refractory partial seizures in this clinical study.

References

	Year	Citations

Page 1